Target intelligence / Profile preview

Human papillomavirus replication cycle

Molecular classification
Other
01

Overview

The human papillomavirus replication cycle refers to the multistage process by which HPV infects host epithelial cells (especially keratinocytes) and replicates its circular double-stranded DNA genome. Upon entry, the viral genome undergoes several distinct replication phases: (1) initial amplification in the basal cell, (2) maintenance replication in concert with the host genome, and (3) vegetative amplification in differentiated keratinocytes leading to virion assembly and release. Key viral proteins involved include E1 and E2 (essential for DNA replication initiation), as well as E6 and E7 (which manipulate host cell cycle and immune pathways). The cycle is closely tied to epithelial cell differentiation and the host cell DNA damage response. The replication cycle is central to HPV pathogenicity and carcinogenesis, especially through persistent infection and eventual expression of viral oncoproteins that drive cellular transformation. The replication cycle itself is not a molecule or receptor but is a critical viral process, involving multiple protein-protein and protein-DNA interactions that are considered for antiviral drug development and therapeutic targeting.

Other names
Human papillomavirus life cycleHPV replicationHPV replication cycle
02

Mechanism of action

Inhibition of E1–E2 protein interaction (essential for viral DNA replication initiation). Inhibition of DNA synthesis by interfering with viral DNA binding and replication initiation. Immunotherapeutic targeting of HPV oncoproteins E6/E7 to disrupt cell transformation.

03

Biological functions

Viral genome replicationViral assemblyHost cell cycle manipulationViral gene expression regulation
04

Disease associations

InfectionCancer (notably cervical and head & neck cancers)Other (benign lesions, warts)
05

Safety considerations

Non-specific inhibition of DNA replication machinery can affect host cellsDevelopment of resistance via viral genome integration or mutationPotential immune evasion by low antigen expression in basal cells
06

Interacting drugs

DNA polymerase inhibitors (investigational)

2 more in the full profile.

07

Biomarkers

Presence of HPV DNA/RNA in tissuesExpression of viral oncoproteins (E6, E7)Surrogate markers such as p16 (in HPV-associated cancers)

Beyond the preview

Go deeper on Human papillomavirus replication cycle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human papillomavirus replication cycle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call